CD30: receptor, marker, target | PLMI
Blockade of tumor necrosis factor superfamily members CD30 and OX40 abrogates disease activity in murine immune-mediated glomerulonephritis - Kidney International
CD30 as a Therapeutic Target for Lymphoma | SpringerLink
Functional aspects of the CD30 gene in Hodgkin's lymphoma and anaplastic large cell lymphoma | SpringerLink
![Anti-CD30 Antibody [CD30/412] - BSA and Azide free (A253829)](https://cdn.antibodies.com/image/catalog/Antibodies/A253/A253829_2.jpg?profile=product_top "Anti-CD30 Antibody [CD30/412] - BSA and Azide free (A253829)")
Anti-CD30 Antibody [CD30/412] - BSA and Azide free (A253829)
Technology | Tessa Therapeutics – Cancer Immunotherapy Treatments
Targeting CD30 helps dual-specificity CAR T cells improve themselves
CD30-dependent degradation of TRAF2: implications for negative regulation of TRAF signaling and the control of cell survival
The role of CD30 and CD153 (CD30L) in the anti-mycobacterial immune response - ScienceDirect
Blocking CD30 on T Cells by a Dual Specific CAR for CD30 and Colon Cancer Antigens Improves the CAR T Cell Response against CD30− Tumors - ScienceDirect
Low CD30 Expression in Non-Hodgkin's Lymphoma Patients Does Not Predict Low Response to Brentuximab Vedotin – Consult QD
CD30 | Welcome to QC Mark
Frontiers | Role of ADAM10 as a CD30 Sheddase in Classical Hodgkin Lymphoma
Functional aspects of the CD30 gene in Hodgkin's lymphoma and anaplastic large cell lymphoma | SpringerLink
Emerging immunotherapies targeting CD30 in Hodgkin's lymphoma - ScienceDirect
Summary of the CD30 signalling transduction pathways in H-RS and ALCL... | Download Scientific Diagram
CD30-REDIRECTED CHIMERIC ANTIGEN RECEPTOR T CELLS TARGET EMBRYONAL CARCINOMA VIA ANTIGEN-DEPENDENT AND FAS/FASL INTERACTIONS | Semantic Scholar
Understanding CD30 biology and therapeutic targeting: a historical perspective providing insight into future directions | Blood Cancer Journal
CD30 signaling and sCD30 working for proliferation of ATL cells. A:... | Download Scientific Diagram
CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features | Haematologica
CAR-CD30 T cells for treatment of CD30+Tumors | Knowledgeshare
Targeting CD30 in Anaplastic Large Cell Lymphoma | SpringerLink
Advances in CD30- and PD-1-targeted therapies for classical Hodgkin lymphoma | Journal of Hematology & Oncology | Full Text
CD30-positive primary cutaneous lymphoproliferative disorders: molecular alterations and targeted therapies | Haematologica
